Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India

BACKGROUND: This post hoc analysis evaluated the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) from India. METHODS: Changes from baseline in HbA(1c), fasting plasma glucose (FPG), body weight, and blood pressure (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasanna Kumar, K. M., Mohan, Viswanathan, Sethi, Bipin, Gandhi, Pramod, Bantwal, Ganapathi, Xie, John, Meininger, Gary, Qiu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855968/
https://www.ncbi.nlm.nih.gov/pubmed/27186557
http://dx.doi.org/10.4103/2230-8210.179996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855968/
https://www.ncbi.nlm.nih.gov/pubmed/27186557
http://dx.doi.org/10.4103/2230-8210.179996

Ejemplares similares